AH Nethersole Hospital, Hong Kong, People's Republic of China
Researchers' work from the People's Republic of China, Canada and Sweden adds to diabetes body of knowledge
Published in Fitness and Wellness Business Week, July 5th, 2006
Study 1: Fosinopril treatment reduced albuminuria and rate of decline in renal function in type 2 diabetic patients with moderate renal insufficiency.
"The renoprotective effect of angiotensin II antagonists has been demonstrated in type 2 diabetic patients with nephropathy but similar data on angiotensin-converting enzyme (ACE) inhibitors are limited. We examined the efficacy and tolerability of fosinopril, an ACE inhibitor with dual hepatic and renal clearance, in 38 type 2 diabetic patients with moderate renal impairment (plasma creatinine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- Aristotelion University of Thessaloniki, Greece
BPD-DS linked to suppressed ghrelin levels and may lead to long-term weight-loss - Duke University, U.S.
Activity-dependent muscle growth requires resident stem cells - Royal Veterinary & Agricultural University, Denmark
Adiponectin and insulin sensitivity mediate favorable effects of low body fat mass on blood lipids - University of Buckingham, U.K.
11 Beta-hydroxysteroid dehydrogenase type 1 inhibition reduces weight gain in obesity model - Albert Einstein College of Medicine, U.S.
Recent studies from the United States and United Kingdom add new data to genetics research - Albert Schweitzer Hospital, Dordrecht, Netherlands
Gallstone risk increases following gastric banding in morbidly obese - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
